San Francisco-based biotech specialist with $5B+ AUM, investing in small and mid-cap listed biotechnology companies as well as private venture rounds. Founded by Oleg Nodelman in 2012.
€10M – €100M
Auto-detected from EcoR1 Capital's website.
Website reachable as of Aug 2026. Focus and check size as listed by the firm, not independently verified.
Learn what EcoR1 Capital and similar investors look for:
Biotech pitch guideA fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.